- Published date :
-
Apr 28, 2009
- Expired date :
-
Apr 28, 2040
April 28, 2009 – Wilmington, DE – Today AstraZeneca (NYSE: AZN) released the following statement in response to the confirmation of a new Secretary of the U.S. Department of Health and Human Services:
“AstraZeneca applauds the confirmation of Kathleen Sebelius as Secretary of Health and Human Services. Secretary Sebelius will provide strong leadership as Congress and the Administration seek to improve the health care system and confront critical public health issues.
“AstraZeneca looks forward to working with Secretary Sebelius on issues that are vital to our nation’s well-being, including increased disease prevention and management, expanded access to quality care, promotion of continuous medical innovation and pursuit of a strong, well-funded FDA.”
About AstraZeneca
AstraZeneca is engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and in the supply of healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with global healthcare sales of $ 31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. In the United States, AstraZeneca is a $13.5 billion dollar healthcare business.
For more information about AstraZeneca in the US or our AZ&Me™ Prescription Savings programs, please visit: www.astrazeneca-us.com.
Media Contacts:
- Tony Jewel, AstraZeneca: 302-885-4594
